Staphylococcus aureus Wood 46 is a facultative anaerobe, mesophilic, Gram-positive human pathogen that produces toxins.
toxin production Gram-positive coccus-shaped facultative anaerobe mesophilic human pathogen genome sequence| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 8735 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 8735 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 39847 | CIP Medium 3 | Medium recipe at CIP |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 93.8 |
| 8735 | Compounddermatoxin |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68371 | 27613 ChEBI | amygdalin | - | builds acid from | from API 50CH acid |
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68371 | 18305 ChEBI | arbutin | - | builds acid from | from API 50CH acid |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68371 | 17057 ChEBI | cellobiose | - | builds acid from | from API 50CH acid |
| 68371 | 17108 ChEBI | D-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18333 ChEBI | D-arabitol | - | builds acid from | from API 50CH acid |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68371 | 15824 ChEBI | D-fructose | + | builds acid from | from API 50CH acid |
| 68371 | 28847 ChEBI | D-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 12936 ChEBI | D-galactose | + | builds acid from | from API 50CH acid |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68371 | 17634 ChEBI | D-glucose | + | builds acid from | from API 50CH acid |
| 68371 | 62318 ChEBI | D-lyxose | - | builds acid from | from API 50CH acid |
| 68375 | 16899 ChEBI | D-mannitol | + | fermentation | from API ID32STA |
| 68371 | 16899 ChEBI | D-mannitol | + | builds acid from | from API 50CH acid |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68371 | 16024 ChEBI | D-mannose | + | builds acid from | from API 50CH acid |
| 68371 | 16988 ChEBI | D-ribose | + | builds acid from | from API 50CH acid |
| 68371 | 17924 ChEBI | D-sorbitol | - | builds acid from | from API 50CH acid |
| 68371 | 16443 ChEBI | D-tagatose | - | builds acid from | from API 50CH acid |
| 68371 | 65327 ChEBI | D-xylose | - | builds acid from | from API 50CH acid |
| 68371 | 17113 ChEBI | erythritol | - | builds acid from | from API 50CH acid |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68371 | 4853 ChEBI | esculin | - | builds acid from | from API 50CH acid |
| 68371 | 16813 ChEBI | galactitol | - | builds acid from | from API 50CH acid |
| 68371 | 28066 ChEBI | gentiobiose | - | builds acid from | from API 50CH acid |
| 68371 | 24265 ChEBI | gluconate | - | builds acid from | from API 50CH acid |
| 68371 | 17754 ChEBI | glycerol | + | builds acid from | from API 50CH acid |
| 68371 | 28087 ChEBI | glycogen | - | builds acid from | from API 50CH acid |
| 39847 | 606565 ChEBI | hippurate | + | hydrolysis | |
| 68371 | 15443 ChEBI | inulin | - | builds acid from | from API 50CH acid |
| 68371 | 30849 ChEBI | L-arabinose | - | builds acid from | from API 50CH acid |
| 68371 | 18403 ChEBI | L-arabitol | - | builds acid from | from API 50CH acid |
| 68371 | 18287 ChEBI | L-fucose | - | builds acid from | from API 50CH acid |
| 68371 | 62345 ChEBI | L-rhamnose | - | builds acid from | from API 50CH acid |
| 68371 | 17266 ChEBI | L-sorbose | - | builds acid from | from API 50CH acid |
| 68371 | 65328 ChEBI | L-xylose | - | builds acid from | from API 50CH acid |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68371 | 17716 ChEBI | lactose | + | builds acid from | from API 50CH acid |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68371 | 17306 ChEBI | maltose | + | builds acid from | from API 50CH acid |
| 68371 | 6731 ChEBI | melezitose | - | builds acid from | from API 50CH acid |
| 68371 | 28053 ChEBI | melibiose | - | builds acid from | from API 50CH acid |
| 68371 | 320061 ChEBI | methyl alpha-D-glucopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 43943 ChEBI | methyl alpha-D-mannoside | - | builds acid from | from API 50CH acid |
| 68371 | 74863 ChEBI | methyl beta-D-xylopyranoside | - | builds acid from | from API 50CH acid |
| 68371 | 17268 ChEBI | myo-inositol | - | builds acid from | from API 50CH acid |
| 68375 | 59640 ChEBI | N-acetylglucosamine | + | fermentation | from API ID32STA |
| 68371 | 59640 ChEBI | N-acetylglucosamine | + | builds acid from | from API 50CH acid |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 39847 | 17632 ChEBI | nitrate | + | reduction | |
| 39847 | 16301 ChEBI | nitrite | - | reduction | |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68371 | Potassium 2-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68371 | Potassium 5-ketogluconate | - | builds acid from | from API 50CH acid | |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68371 | 16634 ChEBI | raffinose | - | builds acid from | from API 50CH acid |
| 68371 | 15963 ChEBI | ribitol | - | builds acid from | from API 50CH acid |
| 68371 | 17814 ChEBI | salicin | - | builds acid from | from API 50CH acid |
| 68371 | 28017 ChEBI | starch | - | builds acid from | from API 50CH acid |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68371 | 17992 ChEBI | sucrose | + | builds acid from | from API 50CH acid |
| 68375 | 27082 ChEBI | trehalose | + | fermentation | from API ID32STA |
| 68371 | 27082 ChEBI | trehalose | + | builds acid from | from API 50CH acid |
| 39847 | 35020 ChEBI | tributyrin | + | hydrolysis | |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| 68371 | 32528 ChEBI | turanose | + | builds acid from | from API 50CH acid |
| 68371 | 17151 ChEBI | xylitol | - | builds acid from | from API 50CH acid |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 68375 | 28368 | novobiocin | 1.8 µg | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 39847 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | + | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 39847 | amylase | - | ||
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 39847 | beta-galactosidase | + | 3.2.1.23 | |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 39847 | caseinase | + | 3.4.21.50 | |
| 8735 | catalase | + | 1.11.1.6 | |
| 39847 | catalase | + | 1.11.1.6 | |
| 39847 | coagulase | + | ||
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 8735 | cytochrome-c oxidase | - | 1.9.3.1 | |
| 39847 | DNase | + | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 39847 | gelatinase | + | ||
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 39847 | lecithinase | + | ||
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 39847 | lipase | + | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 39847 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 39847 | ornithine decarboxylase | - | 4.1.1.17 | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| 39847 | oxidase | - | ||
| 39847 | protease | + | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 39847 | tween esterase | - | ||
| 39847 | urease | + | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
| @ref | ControlQ | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39847 | not determinedn.d. | + | - | - | - | + | - | - | - | - | + | + | + | + | - | - | - | - | + | - | - | - | + | - | - | - | - | - | + | + | - | + | + | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|
| 66792 | 40677_B02 assembly for Staphylococcus aureus NCTC7121 | complete | 1280 | 97.28 | |||
| 66792 | ASM195373v1 assembly for Staphylococcus aureus Wood 46 | contig | 1280 | 68.9 |
| 8735 | GC-content (mol%)31.1 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | oxygen_tolerance | BacteriaNetⓘ | facultative anaerobe | 95.90 | no |
| 125439 | gram_stain | BacteriaNetⓘ | positive | 94.80 | no |
| 125439 | motility | BacteriaNetⓘ | no | 82.40 | no |
| 125439 | spore_formation | BacteriaNetⓘ | no | 93.80 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | yes | 84.30 | no |
| 125438 | anaerobic | anaerobicⓘ | no | 99.31 | yes |
| 125438 | aerobic | aerobicⓘ | no | 52.35 | no |
| 125438 | spore-forming | spore-formingⓘ | no | 72.82 | no |
| 125438 | thermophilic | thermophileⓘ | no | 93.36 | no |
| 125438 | flagellated | motile2+ⓘ | no | 79.89 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Metabolism | Heterogeneity of host TLR2 stimulation by Staphylocoocus aureus isolates. | Hilmi D, Parcina M, Stollewerk D, Ostrop J, Josten M, Meilaender A, Zaehringer U, Wichelhaus TA, Bierbaum G, Heeg K, Wolz C, Bekeredjian-Ding I. | PLoS One | 10.1371/journal.pone.0096416 | 2014 | |
| Synthesis, in vitro and in silico evaluation of halogenated xanthone and benzophenone derivatives as antibacterial agents against acne-causing bacteria. | Devakrishnan P, Nasir NM, Hasan H, Tejo BA, Baharuddin FF. | Bioorg Chem | 10.1016/j.bioorg.2025.108906 | 2025 | ||
| Biotechnology | Validation of the Peel Plate Staphylococcus Aureus (SA) Test for Enumeration of S. aureus in Selected Foods and Non-Cultured Dairy Products: AOAC Performance Tested MethodSM 082401. | Salter RS, Durbin GW, Li S, Gilbert M, Crowley ES, Deterding A, Bastin B. | J AOAC Int | 10.1093/jaoacint/qsae083 | 2025 | |
| Isolation and assessment of probiotic potential of Acidipropionibacterium acidipropionici C03B-STR from goat milk with cholesterol-lowering capability. | Tinrat S, Jiraprasertwong O. | Folia Microbiol (Praha) | 10.1007/s12223-024-01222-8 | 2025 | ||
| Metabolism | Identification of metabolic pathways modulated by GAM and NGAM in the inhibition of Staphylococcus aureus biofilm formation. | Afsharnia A, Nauta A, Groeneveld A, Fernandez-Ciruelos B, Asadpoor M, Folkerts G, Braber S, Wosten M. | Front Microbiol | 10.3389/fmicb.2025.1689343 | 2025 | |
| In vitro antimicrobial activity of Thai stick cannabis Hang Kra Rog Phu Phan (Cannabis sativa L.), sugar leaves extract against pathogenic bacteria. | Pongnaratorn P, Sophon N, Boueroy P. | J Adv Vet Anim Res | 10.5455/javar.2025.l870 | 2025 | ||
| Pathogenicity | A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms. | Kranjec C, Ovchinnikov KV, Gronseth T, Ebineshan K, Srikantam A, Diep DB. | NPJ Biofilms Microbiomes | 10.1038/s41522-020-00166-4 | 2020 | |
| Bacillus licheniformis: A Producer of Antimicrobial Substances, including Antimycobacterials, Which Are Feasible for Medical Applications. | Shleeva MO, Kondratieva DA, Kaprelyants AS. | Pharmaceutics | 10.3390/pharmaceutics15071893 | 2023 | ||
| Isoalantolactone: a review on its pharmacological effects. | Yang G, Yang L, Xu F. | Front Pharmacol | 10.3389/fphar.2024.1453205 | 2024 | ||
| Prosthetic Joint Infection Research Models in NZW Rabbits: Opportunities for Standardization-A Systematic Review. | van Agtmaal JL, van Hoogstraten SWG, Arts JJC. | J Funct Biomater | 10.3390/jfb15100307 | 2024 | ||
| Construction of a Bacterial Lipidomics Analytical Platform: Pilot Validation with Bovine Paratuberculosis Serum. | Wood PL, Erol E. | Metabolites | 10.3390/metabo13070809 | 2023 | ||
| Metabolism | Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm. | de Vor L, van Dijk B, van Kessel K, Kavanaugh JS, de Haas C, Aerts PC, Viveen MC, Boel EC, Fluit AC, Kwiecinski JM, Krijger GC, Ramakers RM, Beekman FJ, Dadachova E, Lam MG, Vogely HC, van der Wal BC, van Strijp JA, Horswill AR, Weinans H, Rooijakkers SH. | Elife | 10.7554/elife.67301 | 2022 | |
| Identification and Application of a Panel of Constitutive Promoters for Gene Overexpression in Staphylococcus aureus. | Liu Q, Li D, Wang N, Guo G, Shi Y, Zou Q, Zhang X. | Front Microbiol | 10.3389/fmicb.2022.818307 | 2022 | ||
| Antimicrobial Activities of Alginate and Chitosan Oligosaccharides Against Staphylococcus aureus and Group B Streptococcus. | Asadpoor M, Ithakisiou GN, van Putten JPM, Pieters RJ, Folkerts G, Braber S. | Front Microbiol | 10.3389/fmicb.2021.700605 | 2021 | ||
| Protective Role of Peroxiredoxin I in Heat-Killed Staphylococcus Aureus-infected Mice. | Sun HN, Liu Y, Wang JN, Wang C, Liu R, Kong LZ, Zhen X, Chandimali N, Cui YD, Kim SU, Lee DS, Yu DY, Kim JS, Jeong DK, Kwon T, Han YH. | In Vivo | 10.21873/invivo.11535 | 2019 | ||
| Isolation and identification of enterotoxigenic Staphylococcus aureus isolates from Indian food samples: evaluation of in-house developed aptamer linked sandwich ELISA (ALISA) method. | Sundararaj N, Kalagatur NK, Mudili V, Krishna K, Antonysamy M. | J Food Sci Technol | 10.1007/s13197-019-03568-1 | 2019 | ||
| Characteristics of an alternative antibacterial biomaterial for mouthwash in the absence of alcohol. | Su CY, Chen CC, Chen HY, Lin CP, Lin FH, Fang HW. | J Dent Sci | 10.1016/j.jds.2019.01.002 | 2019 | ||
| Pathogenicity | Enterotoxin Gene Cluster-Encoded SEI and SElN from Staphylococcus aureus Isolates are Crucial for the Induction of Human Blood Cell Proliferation and Pathogenicity in Rabbits. | Roetzer A, Gruener CS, Haller G, Beyerly J, Model N, Eibl MM. | Toxins (Basel) | 10.3390/toxins8110314 | 2016 | |
| Metabolism | Allicin reduces the production of alpha-toxin by Staphylococcus aureus. | Leng BF, Qiu JZ, Dai XH, Dong J, Wang JF, Luo MJ, Li HE, Niu XD, Zhang Y, Ai YX, Deng XM. | Molecules | 10.3390/molecules16097958 | 2011 | |
| Isolation and Characterization of Bacteria Colonizing Acartia tonsa Copepod Eggs and Displaying Antagonist Effects against Vibrio anguillarum, Vibrio alginolyticus and Other Pathogenic Strains. | Zidour M, Chevalier M, Belguesmia Y, Cudennec B, Grard T, Drider D, Souissi S, Flahaut C. | Front Microbiol | 10.3389/fmicb.2017.01919 | 2017 | ||
| Metabolism | Identification of a staphylococcal complement inhibitor with broad host specificity in equid Staphylococcus aureus strains. | de Jong NWM, Vrieling M, Garcia BL, Koop G, Brettmann M, Aerts PC, Ruyken M, van Strijp JAG, Holmes M, Harrison EM, Geisbrecht BV, Rooijakkers SHM. | J Biol Chem | 10.1074/jbc.ra117.000599 | 2018 | |
| Development of a RPA-CRISPR-Cas12a Assay for Rapid, Simple, and Sensitive Detection of Mycoplasma hominis. | Chen J, Huang Y, Xiao B, Deng H, Gong K, Li K, Li L, Hao W. | Front Microbiol | 10.3389/fmicb.2022.842415 | 2022 | ||
| Naringenin and Its Derivatives-Health-Promoting Phytobiotic against Resistant Bacteria and Fungi in Humans. | Duda-Madej A, Stecko J, Sobieraj J, Szymanska N, Kozlowska J. | Antibiotics (Basel) | 10.3390/antibiotics11111628 | 2022 | ||
| Metabolism | The Staphylococcus aureus polysaccharide capsule and Efb-dependent fibrinogen shield act in concert to protect against phagocytosis. | Kuipers A, Stapels DAC, Weerwind LT, Ko YP, Ruyken M, Lee JC, van Kessel KPM, Rooijakkers SHM. | Microbiology (Reading) | 10.1099/mic.0.000293 | 2016 | |
| Phylogeny | Real-time reverse transcriptase polymerase chain reaction assays for Middle East Respiratory Syndrome. | Douglas CE, Kulesh DA, Jaissle JG, Minogue TD. | Mol Cell Probes | 10.1016/j.mcp.2015.09.001 | 2015 | |
| Recent Advances in the Evaluation of Antimicrobial Materials for Resolution of Orthopedic Implant-Associated Infections In Vivo. | Cyphert EL, Zhang N, Learn GD, Hernandez CJ, von Recum HA. | ACS Infect Dis | 10.1021/acsinfecdis.1c00465 | 2021 | ||
| Identifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts. | Lu DR, Tan YC, Kongpachith S, Cai X, Stein EA, Lindstrom TM, Sokolove J, Robinson WH. | Clin Immunol | 10.1016/j.clim.2014.02.010 | 2014 | ||
| Pathogenicity | The Staphylococcus aureus alpha-toxin perturbs the barrier function in Caco-2 epithelial cell monolayers by altering junctional integrity. | Kwak YK, Vikstrom E, Magnusson KE, Vecsey-Semjen B, Colque-Navarro P, Mollby R. | Infect Immun | 10.1128/iai.00001-12 | 2012 | |
| A systematic review of animal models for Staphylococcus aureus osteomyelitis. | Reizner W, Hunter JG, O'Malley NT, Southgate RD, Schwarz EM, Kates SL. | Eur Cell Mater | 10.22203/ecm.v027a15 | 2014 | ||
| Cytotoxicity and antibacterial activity of gold-supported cerium oxide nanoparticles. | Babu KS, Anandkumar M, Tsai TY, Kao TH, Inbaraj BS, Chen BH. | Int J Nanomedicine | 10.2147/ijn.s70087 | 2014 | ||
| Pathogenicity | A Review on Flavonoid Apigenin: Dietary Intake, ADME, Antimicrobial Effects, and Interactions with Human Gut Microbiota. | Wang M, Firrman J, Liu L, Yam K. | Biomed Res Int | 10.1155/2019/7010467 | 2019 | |
| Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency. | Tkaczyk C, Hua L, Varkey R, Shi Y, Dettinger L, Woods R, Barnes A, MacGill RS, Wilson S, Chowdhury P, Stover CK, Sellman BR. | Clin Vaccine Immunol | 10.1128/cvi.05589-11 | 2012 | ||
| Identification of a new repetitive element in Staphylococcus aureus. | Cramton SE, Schnell NF, Gotz F, Bruckner R. | Infect Immun | 10.1128/iai.68.4.2344-2348.2000 | 2000 | ||
| Metabolism | Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides. | Basi-Chipalu S, Dischinger J, Josten M, Szekat C, Zweynert A, Sahl HG, Bierbaum G. | Appl Environ Microbiol | 10.1128/aem.00299-15 | 2015 | |
| Chemical modification of capuramycins to enhance antibacterial activity. | Bogatcheva E, Dubuisson T, Protopopova M, Einck L, Nacy CA, Reddy VM. | J Antimicrob Chemother | 10.1093/jac/dkq495 | 2011 | ||
| Metabolism | Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. | Cramton SE, Ulrich M, Gotz F, Doring G. | Infect Immun | 10.1128/iai.69.6.4079-4085.2001 | 2001 | |
| Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850. | Lam TT, Giese B, Chikkaballi D, Kuhn A, Wolber W, Pane-Farre J, Schafer D, Engelmann S, Fraunholz M, Sinha B. | Infect Immun | 10.1128/iai.00012-10 | 2010 | ||
| Biotechnology | Validation of the One Broth One Plate for Salmonella Method for Detection of Salmonella Spp. in Select Food and Environmental Samples: AOAC Performance Tested MethodSM 102002. | Alles S, Roman B, Le QN, Kurteu M, Elmerhebi E, Potter C, Mozola M, Thompson W, Bastin B, Donofrio R. | J AOAC Int | 10.1093/jaoacint/qsaa149 | 2021 | |
| Metabolism | Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. | Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G. | PLoS One | 10.1371/journal.pone.0006788 | 2009 | |
| Analogs of Eap protein are conserved and prevalent in clinical Staphylococcus aureus isolates. | Hussain M, Becker K, von Eiff C, Peters G, Herrmann M. | Clin Diagn Lab Immunol | 10.1128/cdli.8.6.1271-1276.2001 | 2001 | ||
| The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. | Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. | Infect Immun | 10.1128/iai.67.10.5427-5433.1999 | 1999 | ||
| Genomic fingerprints of Staphylococcus aureus of bovine origin by polymerase chain reaction-based DNA fingerprinting. | Matthews KR, Kumar SJ, O'Conner SA, Harmon RJ, Pankey JW, Fox LK, Oliver SP. | Epidemiol Infect | 10.1017/s095026880005754x | 1994 | ||
| Metabolism | Replication of simian virus 40 (SV40) DNA in virus-infected CV1 cells selectively permeabilized for small molecules by Staphylococcus aureus alpha-toxin: involvement of mitochondria in the fast O2-dependent regulation of SV40 DNA replication. | Riedinger HJ, Eger F, Trummler K, Probst H. | Biochem J | 10.1042/bj20040492 | 2005 | |
| Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model. | Menzies BE, Kernodle DS. | Infect Immun | 10.1128/iai.62.5.1843-1847.1994 | 1994 | ||
| Simultaneous identification of antibodies to Brucella abortus and Staphylococcus aureus in milk samples by flow cytometry. | Iannelli D, D'Apice L, Fenizia D, Serpe L, Cottone C, Viscardi M, Capparelli R. | J Clin Microbiol | 10.1128/jcm.36.3.802-806.1998 | 1998 | ||
| Metabolism | Identification and characterization of a novel 38.5-kilodalton cell surface protein of Staphylococcus aureus with extended-spectrum binding activity for extracellular matrix and plasma proteins. | Hussain M, Becker K, von Eiff C, Schrenzel J, Peters G, Herrmann M. | J Bacteriol | 10.1128/jb.183.23.6778-6786.2001 | 2001 | |
| Metabolism | Surface properties of Staphylococcus aureus isolated from caprine mastitis. | Jarp J, Mamo W, Johne B. | Acta Vet Scand | 10.1186/bf03548040 | 1989 | |
| Antimicrobial Activity of Lactoferrin-Related Peptides and Applications in Human and Veterinary Medicine. | Bruni N, Capucchio MT, Biasibetti E, Pessione E, Cirrincione S, Giraudo L, Corona A, Dosio F. | Molecules | 10.3390/molecules21060752 | 2016 | ||
| Metabolism | Molecular cloning and characterization of three beta-defensins from canine testes. | Sang Y, Ortega MT, Blecha F, Prakash O, Melgarejo T. | Infect Immun | 10.1128/iai.73.5.2611-2620.2005 | 2005 | |
| Enzymology | Antibodies against staphylococcal and streptococcal nucleases in bovine blood serum and milk. | Gudding R. | Acta Vet Scand | 10.1186/bf03546887 | 1980 | |
| Staphylococcus aureus exopolysaccharide in vivo demonstrated by immunomagnetic separation and electron microscopy. | Johne B, Jarp J, Haaheim LR. | J Clin Microbiol | 10.1128/jcm.27.7.1631-1635.1989 | 1989 | ||
| Metabolism | Binding of Staphylococcus aureus by human serum spreading factor in an in vitro assay. | Fuquay JI, Loo DT, Barnes DW. | Infect Immun | 10.1128/iai.52.3.714-717.1986 | 1986 | |
| Pathogenicity | Adenosine and 2-phenylaminoadenosine (CV-1808) inhibit human neutrophil bactericidal function. | Hardart GE, Sullivan GW, Carper HT, Mandell GL. | Infect Immun | 10.1128/iai.59.3.885-889.1991 | 1991 | |
| Staphylococcus aureus antigens reactive with milk immunoglobulin G of naturally infected dairy cows. | Adams DS, McDonald JS, Hancock D, McGuire TC. | J Clin Microbiol | 10.1128/jcm.26.6.1175-1180.1988 | 1988 | ||
| Enzymology | Differentiation of staphylococci on the basis of nuclease properties. | Gudding R. | J Clin Microbiol | 10.1128/jcm.18.5.1098-1101.1983 | 1983 | |
| Antibody response to teichoic acid and peptidoglycan in Staphylococcus aureus osteomyelitis. | Jacob E, Durham LC, Falk MC, Williams TJ, Wheat LJ. | J Clin Microbiol | 10.1128/jcm.25.1.122-127.1987 | 1987 | ||
| Pathogenicity | Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus. | Moorman DR, Mandell GL. | Antimicrob Agents Chemother | 10.1128/aac.20.6.709 | 1981 | |
| Cellular location of alpha-hemolysin in Staphylococcus aureus. | Nugent KM, Calandra GB, Theodore TS. | Infect Immun | 10.1128/iai.12.2.270-273.1975 | 1975 | ||
| Phylogeny | Restriction endonuclease fingerprinting of genomic DNA of Staphylococcus species of bovine origin. | Matthews KR, Jayarao BM, Oliver SP. | Epidemiol Infect | 1992 | ||
| Enzymology | Cloning and expression of the Staphylococcus aureus protein A gene in Escherichia coli. | Duggleby CJ, Jones SA. | Nucleic Acids Res | 10.1093/nar/11.10.3065 | 1983 | |
| Metabolism | Binding of human immunoglobulin G to protein A in encapsulated Staphylococcus aureus. | King BF, Wilkinson BJ. | Infect Immun | 10.1128/iai.33.3.666-672.1981 | 1981 | |
| Metabolism | Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent. | Goodrum KJ, McCormick LL, Schneider B. | Infect Immun | 10.1128/iai.62.8.3102-3107.1994 | 1994 | |
| Vaginal isolates of Staphylococcus aureus associated with toxic shock syndrome. | Barbour AG. | Infect Immun | 10.1128/iai.33.2.442-449.1981 | 1981 | ||
| Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance. | Mandell GL, Moorman DR. | Antimicrob Agents Chemother | 10.1128/aac.17.4.658 | 1980 | ||
| Specific and nonspecific staining in detecting staphylococcal alpha toxin on erythrocytes by immunofluorescence. | Kaplan MT. | Infect Immun | 10.1128/iai.5.5.831-832.1972 | 1972 | ||
| Proton motive force in growing Streptococcus lactis and Staphylococcus aureus cells under aerobic and anaerobic conditions. | Kashket ER. | J Bacteriol | 10.1128/jb.146.1.369-376.1981 | 1981 | ||
| Rapid focused sequencing: a multiplexed assay for simultaneous detection and strain typing of Bacillus anthracis, Francisella tularensis, and Yersinia pestis. | Turingan RS, Thomann HU, Zolotova A, Tan E, Selden RF. | PLoS One | 10.1371/journal.pone.0056093 | 2013 | ||
| Phylogeny | Deoxyribonucleic acid base composition in the taxonomy of Staphylococcus. | Garrity FL, Detrick B, Kennedy ER. | J Bacteriol | 10.1128/jb.97.2.557-560.1969 | 1969 | |
| Enzymology | Molecular detection of persistent Borrelia burgdorferi in the urine of patients with active Lyme disease. | Goodman JL, Jurkovich P, Kramber JM, Johnson RC. | Infect Immun | 10.1128/iai.59.1.269-278.1991 | 1991 | |
| Pathogenicity | Bacteriostatic action of progesterone on staphylococci and other microorganisms. | Yotis W, Stanke R. | J Bacteriol | 10.1128/jb.92.5.1285-1289.1966 | 1966 | |
| Cutaneous infection in normal and immunocompromised mice. | Kraft WG, Johnson PT, David BC, Morgan DR. | Infect Immun | 10.1128/iai.52.3.707-713.1986 | 1986 | ||
| Induction of phagocytic inhibitory activity in cats with chronic Pseudomonas aeruginosa pulmonary infection. | Winnie GB, Klinger JD, Sherman JM, Thomassen MJ. | Infect Immun | 10.1128/iai.38.3.1088-1093.1982 | 1982 | ||
| Phylogeny | Simplified lyogroup system, a new method for routine identification of staphylococci: description and comparison with three other methods. | Varaldo PE, Grazi G, Soro O, Cisani G, Satta G. | J Clin Microbiol | 10.1128/jcm.12.1.63-68.1980 | 1980 | |
| Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity. | Bogard WC, Dunn DL, Abernethy K, Kilgarriff C, Kung PC. | Infect Immun | 10.1128/iai.55.4.899-908.1987 | 1987 | ||
| Immunological characteristics of gonococcal outer membrane protein II assessed by immunoprecipitation, immunoblotting, and coagglutination. | Swanson J, Barrera O. | J Exp Med | 10.1084/jem.157.5.1405 | 1983 | ||
| Pathogenicity | Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response. | Painter KL, Strange E, Parkhill J, Bamford KB, Armstrong-James D, Edwards AM. | Infect Immun | 10.1128/iai.03016-14 | 2015 | |
| Pathogenicity | The Immunomodulatory Drug Glatiramer Acetate is Also an Effective Antimicrobial Agent that Kills Gram-negative Bacteria. | Christiansen SH, Murphy RA, Juul-Madsen K, Fredborg M, Hvam ML, Axelgaard E, Skovdal SM, Meyer RL, Sorensen UBS, Moller A, Nyengaard JR, Norskov-Lauritsen N, Wang M, Gadjeva M, Howard KA, Davies JC, Petersen E, Vorup-Jensen T. | Sci Rep | 10.1038/s41598-017-15969-3 | 2017 | |
| Metabolism | Protein A and coagulase expression in epidemic and non-epidemic Staphylococcus aureus. | Roberts JI, Gaston MA. | J Clin Pathol | 10.1136/jcp.40.8.837 | 1987 | |
| Pathogenicity | TWO VARIANTS OF STAPHYLOCOCCUS AUREUS WOOD 46 (NCTC 7121) DIFFERING IN RESPECT TO ALPHA TOXIN PRODUCTION. | KJEMS E. | J Bacteriol | 10.1128/jb.86.5.1127-1128.1963 | 1963 | |
| Inhibition of leukocyte migration by a staphylococcal factor. | Weksler BB, Hill MJ. | J Bacteriol | 10.1128/jb.98.3.1030-1035.1969 | 1969 | ||
| Phylogeny | Numerical analysis of electrophoretic protein patterns of methicillin-resistant strains of Staphylococcus aureus. | Costas M, Cookson BD, Talsania HG, Owen RJ. | J Clin Microbiol | 10.1128/jcm.27.11.2574-2581.1989 | 1989 | |
| Pathogenicity | Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria. | Vosbeck K, James PR, Zimmermann W. | Antimicrob Agents Chemother | 10.1128/aac.25.6.735 | 1984 | |
| Pathogenicity | Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro. | Labro MT, Amit N, Babin-Chevaye C, Hakim J. | Antimicrob Agents Chemother | 10.1128/aac.30.1.137 | 1986 | |
| Metabolism | Interactions between antibiotic-producing and non-producing staphylococci in skin surface and sub-surface models. | Noble WC, Willie JA. | Br J Exp Pathol | 1980 | ||
| Metabolism | Purification and properties of staphylococcal delta-hemolysin. I. Production of delta-hemolysin. | Murphy RA, Haque R. | J Bacteriol | 10.1128/jb.94.5.1327-1333.1967 | 1967 | |
| Pathogenicity | Nonenteric toxins of Staphylococcus aureus. | Rogolsky M. | Microbiol Rev | 10.1128/mr.43.3.320-360.1979 | 1979 | |
| Studies on antistreptolysin O activity generated in serum by microorganisms. | Watson KC, Kerr EJ. | Br J Exp Pathol | 1976 | |||
| Pathogenicity | Effect immunization with highly purified alpha- and beta-toxins on staphylococcal mastitis in rabbits. | Adlam C, Ward PD, McCartney AC, Arbuthnott JP, Thorley CM. | Infect Immun | 10.1128/iai.17.2.250-256.1977 | 1977 | |
| Metabolism | Production, purification, and composition of staphylococcal alpha toxin. | Coulter JR. | J Bacteriol | 10.1128/jb.92.6.1655-1662.1966 | 1966 | |
| Subcutaneous staphylococcal infection in mice. II. The inflammatory response to different strains of staphylococci and micrococci. | Agarwal DS. | Br J Exp Pathol | 1967 | |||
| Sub-growth-inhibitory concentrations of omadacycline inhibit Staphylococcus aureus haemolytic activity in vitro. | Serio AW, Tanaka SK, Wright K, Garrity-Ryan L | JAC Antimicrob Resist | 10.1093/jacamr/dlab190 | 2021 | ||
| Metabolism | Molecular basis of surface anchored protein A deficiency in the Staphylococcus aureus strain Wood 46. | Balachandran M, Giannone RJ, Bemis DA, Kania SA | PLoS One | 10.1371/journal.pone.0183913 | 2017 | |
| Genetics | Complete Genome Sequence of Staphylococcus aureus Strain Wood 46. | Balachandran M, Riley MC, Bemis DA, Kania SA | Genome Announc | 10.1128/genomeA.00087-17 | 2017 | |
| Pathogenicity | Combined influence of teichoic acids from Staphylococcus aureus and heterometallik Cu/Cd ethylenediamine complex on peritoneal macrophages and tumor cells. | Nikulina VV, Garmanchuk LV, Senchylo NV, Nikolaenko TV, Dzhus OI, Ostapchenko LI, Khranovska NM | Tsitol Genet | 2014 | ||
| Synthesis, characterization and antibacterial activity of superparamagnetic nanoparticles modified with glycol chitosan. | Stephen Inbaraj B, Tsai TY, Chen BH | Sci Technol Adv Mater | 10.1088/1468-6996/13/1/015002 | 2012 | ||
| Pathogenicity | The synthesis and characterization of poly(gamma-glutamic acid)-coated magnetite nanoparticles and their effects on antibacterial activity and cytotoxicity. | Inbaraj BS, Kao TH, Tsai TY, Chiu CP, Kumar R, Chen BH | Nanotechnology | 10.1088/0957-4484/22/7/075101 | 2011 | |
| Pathogenicity | More than one tandem repeat domain of the extracellular adherence protein of Staphylococcus aureus is required for aggregation, adherence, and host cell invasion but not for leukocyte activation. | Hussain M, Haggar A, Peters G, Chhatwal GS, Herrmann M, Flock JI, Sinha B | Infect Immun | 10.1128/IAI.00480-08 | 2008 | |
| Release of tobramycin from tobramycin-containing bone cement in bone and serum of rabbits. | Nijhof MW, Dhert WJ, Tilman PB, Verbout AJ, Fleer A | J Mater Sci Mater Med | 10.1023/a:1018577032259 | 1997 | ||
| Enzymology | Variation of the agr locus in Staphylococcus aureus isolates from cows with mastitis. | Takeuchi S, Maeda T, Hashimoto N, Imaizumi K, Kaidoh T, Hayakawa Y | Vet Microbiol | 10.1016/s0378-1135(00)00354-0 | 2001 | |
| Metabolism | Involvement of staphylococcal protein A and cytoskeletal actin in Staphylococcus aureus invasion of cultured human oral epithelial cells. | Jung KY, Cha JD, Lee SH, Woo WH, Lim DS, Choi BK, Kim KJ | J Med Microbiol | 10.1099/0022-1317-50-1-35 | 2001 | |
| Metabolism | Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. | Genovese A, Bouvet JP, Florio G, Lamparter-Schummert B, Bjorck L, Marone G | Infect Immun | 10.1128/IAI.68.10.5517-5524.2000 | 2000 | |
| Evaluation of standard surgical preparation performed on superficial dermal abrasions. | Jeray KJ, Banks DM, Phieffer LS, Middlebrooks ES, Frankenburg KP, Hudson MC, Kellam JF, Bosse MJ | J Orthop Trauma | 10.1097/00005131-200003000-00011 | 2000 | ||
| Metabolism | Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets. | Nguyen T, Ghebrehiwet B, Peerschke EI | Infect Immun | 10.1128/IAI.68.4.2061-2068.2000 | 2000 | |
| Material and design in haematogenous implant-associated infections in a rabbit model. | Johansson A, Lindgren JU, Nord CE, Svensson O | Injury | 10.1016/s0020-1383(99)00152-7 | 1999 | ||
| Pathogenicity | Escherichia coli and Proteus mirabilis inhibit the perinuclear but not the circulating antineutrophil cytoplasmic antibody reaction. | Yang P, Danielsson D, Jarnerot G | Scand J Gastroenterol | 10.1080/00365529850172115 | 1998 | |
| Metabolism | Analysis of expression of the alpha-toxin gene (hla) of Staphylococcus aureus by using a chromosomally encoded hla::lacZ gene fusion. | Ohlsen K, Koller KP, Hacker J | Infect Immun | 10.1128/iai.65.9.3606-3614.1997 | 1997 | |
| Pathogenicity | [Effects of Staphylococcus aureus protein A on the production of primary host defense factors against S. aureus infection]. | Endo N, Onogawa T | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.71.39 | 1997 | |
| Metabolism | Adhesion of Staphylococcus aureus to horny layer: role of fibrinogen. | Kanzaki H, Morishita Y, Akiyama H, Arata J | J Dermatol Sci | 10.1016/0923-1811(95)00472-6 | 1996 | |
| Detection of antibodies to Staphylococcus aureus in water buffalo milk by flow cytometry. | D'Apice L, Fenizia D, Capparelli R, Scala F, Iannelli D | Res Vet Sci | 10.1016/s0034-5288(96)90015-6 | 1996 | ||
| Metabolism | [Effects of solar and geomagnetic activity on the accuracy of laboratory methods in differentiation of Staphylococcus aureus and S. epidermidis]. | Polikarpov NA | Klin Lab Diagn | 1995 | ||
| Pathogenicity | Staphylococcal protein A induces biased production of Ig by VH3-expressing B lymphocytes. | Kristiansen SV, Pascual V, Lipsky PE | J Immunol | 1994 | ||
| Pathogenicity | Staphylococcus aureus Wood 46 strain activates human B cells without affecting DNA synthesis or tyrosine phosphorylation. | Saiki O, Kawamoto M, Fukuzumi M, Kanou M, Utsumi S | J Immunol | 1993 | ||
| Enzymology | Assembly and channel-forming activity of a naturally-occurring nicked molecule of Staphylococcus aureus alpha-toxin. | Tomita T, Watanabe M, Yarita Y | Biochim Biophys Acta | 10.1016/0005-2736(93)90380-i | 1993 | |
| Metabolism | Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. | Bredius RG, Driedijk PC, Schouten MF, Weening RS, Out TA | Infect Immun | 10.1128/iai.60.11.4838-4847.1992 | 1992 | |
| Location of peptidoglycan and teichoic acid on the cell wall surface of Staphylococcus aureus as determined by immunoelectron microscopy. | Umeda A, Yokoyama S, Arizono T, Amako K | J Electron Microsc (Tokyo) | 1992 | |||
| Pathogenicity | Distribution of capsular materials on the cell wall surface of strain Smith diffuse of Staphylococcus aureus. | Arizono T, Umeda A, Amako K | J Bacteriol | 10.1128/jb.173.14.4333-4340.1991 | 1991 | |
| Pathogenicity | Effect of metalloproteinase from Staphylococcus aureus on in vitro stimulation of human lymphocytes. | Prokesova L, Porwit-Bobr Z, Baran K, Potempa J, Pospisil M, John C | Immunol Lett | 10.1016/0165-2478(91)90156-5 | 1991 | |
| Metabolism | Expression of clumping and fibrinogen-binding activities of Staphylococcus aureus at various growth stages. | Yonemasu K, Sasaki T, Ohmae R, Kashiba S | Microbiol Immunol | 10.1111/j.1348-0421.1991.tb01571.x | 1991 | |
| Pathogenicity | Cryptic alpha-toxin gene in toxic shock syndrome and septicaemia strains of Staphylococcus aureus. | O'Reilly M, Kreiswirth B, Foster TJ | Mol Microbiol | 10.1111/j.1365-2958.1990.tb02044.x | 1990 | |
| Pathogenicity | The patterns of extracellular protein formation by spontaneously-occurring rifampicin-resistant mutants of Staphylococcus aureus. | al-Ani B, Aboshkiwa M, Glass RE, Coleman G | FEMS Microbiol Lett | 10.1016/0378-1097(90)90108-3 | 1990 | |
| Metabolism | Binding of a Staphylococcus aureus bone pathogen to type I collagen. | Buxton TB, Rissing JP, Horner JA, Plowman KM, Scott DF, Sprinkle TJ, Best GK | Microb Pathog | 10.1016/0882-4010(90)90031-k | 1990 | |
| Pathogenicity | Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin. | Bouchenaki N, Vaudaux PE, Huggler E, Waldvogel FA, Lew DP | Antimicrob Agents Chemother | 10.1128/AAC.34.1.21 | 1990 | |
| Pathogenicity | Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. | Vaudaux P, Pittet D, Haeberli A, Huggler E, Nydegger UE, Lew DP, Waldvogel FA | J Infect Dis | 10.1093/infdis/160.5.865 | 1989 | |
| Pathogenicity | [Specific IgE to Staphylococcus aureus in patients with atopic dermatitis]. | Kapp A, Schopf E | Hautarzt | 1989 | ||
| Phylogeny | Inhibition by immunoglobulins of Staphylococcus aureus adherence to fibronectin-coated foreign surfaces. | Vaudaux PE, Huggler E, Lerch PG, Morgenthaler JJ, Nydegger UE, Schumacher-Perdreau F, Lew PD, Waldvogel FA | J Invest Surg | 10.3109/08941938909018265 | 1989 | |
| Metabolism | Study of Staphylococcus aureus teichoic acid immunodominant site by help of synthetic haptens. | Perouse de Montclos M, Boullanger P, Flandrois JP | Zentralbl Bakteriol Mikrobiol Hyg A | 10.1016/s0176-6724(88)80058-0 | 1988 | |
| Enzymology | Purification of alpha-toxin from Staphylococcus aureus and application to cell permeabilization. | Lind I, Ahnert-Hilger G, Fuchs G, Gratzl M | Anal Biochem | 10.1016/0003-2697(87)90371-x | 1987 | |
| Pathogenicity | [Serological diagnosis of suppurative-septic diseases of staphylococcal etiology]. | Deriabin PN, Karal'nik BV, Vaneeva NP, Slastikhin BA, Tereshchenko LI | Zh Mikrobiol Epidemiol Immunobiol | 1987 | ||
| Metabolism | Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. | Tashiro M, Ciborowski P, Reinacher M, Pulverer G, Klenk HD, Rott R | Virology | 10.1016/0042-6822(87)90284-4 | 1987 | |
| Pathogenicity | Role of bacterial exopolymers and host factors on adherence and phagocytosis of Staphylococcus aureus in foreign body infection. | Falcieri E, Vaudaux P, Huggler E, Lew D, Waldvogel F | J Infect Dis | 10.1093/infdis/155.3.524 | 1987 | |
| Pathogenicity | Mechanism of activation of human basophils by Staphylococcus aureus Cowan 1. | Marone G, Tamburini M, Giudizi MG, Biagiotti R, Almerigogna F, Romagnani S | Infect Immun | 10.1128/iai.55.3.803-809.1987 | 1987 | |
| Pathogenicity | Increased in vitro cell-mediated immune response to staphylococcal antigens in atopic dermatitis. | Higaki Y, Hauser C, Rilliet A, Saurat JH | J Am Acad Dermatol | 10.1016/s0190-9622(86)70291-0 | 1986 | |
| Pathogenicity | Anti-Staphylococcus aureus-specific IgE in atopic dermatitis. | Motala C, Potter PC, Weinberg EG, Malherbe D, Hughes J | J Allergy Clin Immunol | 10.1016/0091-6749(86)90075-8 | 1986 | |
| [Comparative evaluation of the diagnostic effectiveness of staphylococcal allergens of different manufacture in bronchospastic reactions of sensitized lungs]. | Shamsutdinova GS, Sukhodoeva GS, Beliaev NN, Beklemishev ND, Iskhakova SKh | Zh Mikrobiol Epidemiol Immunobiol | 1986 | |||
| Pathogenicity | Polyclonal antibody formation of human lymphocytes to bacterial components. | Rasanen L, Lehto M, Jokinen I, Leinikki P | Immunology | 1986 | ||
| Pathogenicity | Adherence of gram-positive and gram-negative bacterial strains to human lung fibroblasts in vitro. | Martin D, Mathieu LG, Lecomte J, deRepentigny J | Exp Biol | 1986 | ||
| Pathogenicity | Attachment of Staphylococcus aureus to polymethylmethacrylate increases its resistance to phagocytosis in foreign body infection. | Vaudaux PE, Zulian G, Huggler E, Waldvogel FA | Infect Immun | 10.1128/iai.50.2.472-477.1985 | 1985 | |
| Pathogenicity | Antibody response against whole Staphylococcus aureus in patients with staphylococcal septicaemia and endocarditis investigated by ELISA. | Jarlov JO, Christensson B, Espersen F, Hertz JB, Hedstrom SA | Acta Pathol Microbiol Immunol Scand B | 10.1111/j.1699-0463.1985.tb02893.x | 1985 | |
| Pathogenicity | Introduction of bacterial components in postadsorbed plasma during adsorption with Staphylococcus aureus. | Bandyopadhyay SK, Ray PK | Cancer | 10.1002/1097-0142(19850715)56:2<266::aid-cncr2820560211>3.0.co;2-w | 1985 | |
| Staphylococcus aureus-induced suppression of contact sensitivity in mice: suppressor cells elicited by polyclonal B-cell activation are regulated by idiotype--anti-idiotype interactions. | Benedettini G, De Libero G, Mori L, Marelli P, Angioni MR, Campa M | Cell Immunol | 10.1016/0008-8749(85)90155-8 | 1985 | ||
| Pathogenicity | Activation of human basophils by Staphylococcus aureus Cowan I. II. Alternative F(ab')-mediated mechanism. | Marone G, Tamburini M, Giudizi MG, Biagiotti R, Almerigogna F, Romagnani S | Agents Actions | 10.1007/BF01982873 | 1985 | |
| Enzymology | Purification of oligomeric staphylococcal alpha-toxin by affinity chromatography on digitonin-sepharose. | Schaeg W, Kranz T, Bruckler J, Blobel H | Zentralbl Bakteriol Mikrobiol Hyg A | 10.1016/s0176-6724(85)80009-2 | 1985 | |
| Enzymology | A comparison of the patterns of extracellular proteins produced by the high alpha-toxin-secreting organism Staphylococcus aureus (Wood 46) during aerobic and anaerobic growth. | Coleman G | J Gen Microbiol | 10.1099/00221287-131-2-405 | 1985 | |
| Metabolism | Effect of antibodies directed against complement receptors on phagocytosis by polymorphonuclear leukocytes: use of iodination as a convenient measure of phagocytosis. | Klebanoff SJ, Beatty PG, Schreiber RD, Ochs HD, Waltersdorph AM | J Immunol | 1985 | ||
| Experimental hematogenous infection of subcutaneously implanted foreign bodies. | Zimmerli W, Zak O, Vosbeck K | Scand J Infect Dis | 10.3109/inf.1985.17.issue-3.10 | 1985 | ||
| Pathogenicity | Enzyme-linked immunosorbent assay (ELISA) for isotype-specific quantitation of antibodies to Staphylococcus aureus in patients with atopic dermatitis. | Gabrielsen TO, Brandtzaeg P | Acta Derm Venereol Suppl (Stockh) | 10.2340/000155551146166 | 1985 | |
| Pathogenicity | Immunosuppressor control as a modality of cancer treatment: effect of plasma adsorption with Staphylococcus aureus protein A. | Ray PK | Contemp Top Immunobiol | 10.1007/978-1-4684-4931-0_5 | 1985 | |
| Enzymology | Effect of phenethyl alcohol on Staphylococcus aureus alpha-lysin production. | Lee KY, Birkbeck TH | Infect Immun | 10.1128/iai.47.1.112-117.1985 | 1985 | |
| Pathogenicity | Activation of human basophils by bacterial products. | Marone G, Columbo M, Tamburini M, Romagnani S | Int Arch Allergy Appl Immunol | 10.1159/000233790 | 1985 | |
| Metabolism | Characterization of immunoglobulin G binding to Staphylococcus aureus strain Wood 46. | Amend A, Chhatwal GS, Schaeg W, Blobel H | Zentralbl Bakteriol Mikrobiol Hyg A | 10.1016/s0176-6724(84)80024-3 | 1984 | |
| Enzymology | Opsonic activity of immunoglobulin prepared for intravenous use. | Hetherington SV, Giebink GS | J Lab Clin Med | 0022-2143(84)90054-4 | 1984 | |
| Pathogenicity | Inhibition of secretion of staphylococcal alpha toxin by cerulenin. | Saleh FA, Freer JH | J Med Microbiol | 10.1099/00222615-18-2-205 | 1984 | |
| Metabolism | Binding of 125I-alpha toxin of Staphylococcus aureus to erythrocytes. | Phimister GM, Freer JH | J Med Microbiol | 10.1099/00222615-18-2-197 | 1984 | |
| Pathogenicity | Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. | Vaudaux P, Suzuki R, Waldvogel FA, Morgenthaler JJ, Nydegger UE | J Infect Dis | 10.1093/infdis/150.4.546 | 1984 | |
| Adsorption of fibronectin onto polymethylmethacrylate and promotion of Staphylococcus aureus adherence. | Vaudaux PE, Waldvogel FA, Morgenthaler JJ, Nydegger UE | Infect Immun | 10.1128/iai.45.3.768-774.1984 | 1984 | ||
| Pathogenicity | Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer. | Langone JJ, Das C, Bennett D, Terman DS | J Immunol | 1984 | ||
| Enzymology | [Diagnosis of staphylococcal diseases using an immunoenzyme reaction]. | Vaneeva NP, Tsvetkova NV, Gudkova RG, Deriabin PN | Zh Mikrobiol Epidemiol Immunobiol | 1984 | ||
| Metabolism | Induction of immunoglobulin secretion in cultured human lymphocytes by 4 Staphylococcus aureus strains and their extracts. | Effersoe H, Espersen F, Andersen V | Acta Pathol Microbiol Immunol Scand C | 10.1111/j.1699-0463.1984.tb00062.x | 1984 | |
| Metabolism | Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. | Zimmerli W, Lew PD, Waldvogel FA | J Clin Invest | 10.1172/JCI111305 | 1984 | |
| Pathogenicity | Effects of fibronectin on the compact colony formation in staphylococci. | Usui Y, Ohshima Y, Yoshida K | Can J Microbiol | 10.1139/m84-062 | 1984 | |
| Pathogenicity | Whole organisms and purified cell walls compared as immunosorbents for the detection of IgE antibodies to Staphylococcus aureus. | Friedman SJ, Schroeter AL, Homburger HA | J Immunol Methods | 10.1016/0022-1759(84)90350-8 | 1984 | |
| B cell activation in chickens induced by Staphylococcus aureus. | Schoof DD, Tempelis CH | Dev Comp Immunol | 10.1016/0145-305x(84)90047-8 | 1984 | ||
| Pathogenicity | Adsorption of plasma from tumor-bearing hosts over protein A--containing nonviable Staphylococcus aureus Cowan I: possible mechanism of antitumor reactions. | Ray PK, McLaughlin D, Allen P, Bandyopadhyay S, Idiculla A, Clarke L, Mark R, Rhoads JE Jr, Bassett JG, Cooper DR | J Biol Response Mod | 1984 | ||
| Pathogenicity | In vitro tumoricidal activity of immunoadsorbed leukemic serum. | Miller WJ, Branda RF | J Biol Response Mod | 1984 | ||
| Metabolism | Radioimmunoassays for protein A of Staphylococcus aureus. | Langone JJ, Das C, Bennett D, Terman DS | J Immunol Methods | 10.1016/0022-1759(83)90419-2 | 1983 | |
| Enzymology | Cloning, expression, and mapping of the Staphylococcus aureus alpha-hemolysin determinant in Escherichia coli K-12. | Kehoe M, Duncan J, Foster T, Fairweather N, Dougan G | Infect Immun | 10.1128/iai.41.3.1105-1111.1983 | 1983 | |
| Pathogenicity | Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies. | Tshefu K, Zimmerli W, Waldvogel FA | Rev Infect Dis | 10.1093/clinids/5.supplement_3.s474 | 1983 | |
| Metabolism | The effect of glucose on the differential rates of extracellular protein and alpha-toxin formation by Staphylococcus aureus (Wood 46). | Coleman G | Arch Microbiol | 10.1007/BF00407759 | 1983 | |
| Effect of Butylated Hydroxyanisole on the Cytoplasmic Membrane of Staphylococcus aureus Wood 46. | Degre R, Sylvestre M | J Food Prot | 10.4315/0362-028X-46.3.206 | 1983 | ||
| Phylogeny | New possibilities of staphylococcin detection in the exfoliatin-producing strains of staphylococcus aureus. | Skalka B, Pillich J, Pospisil L | Zentralbl Bakteriol Mikrobiol Hyg A | 1983 | ||
| Pathogenicity | Pathogenesis of foreign body infection: description and characteristics of an animal model. | Zimmerli W, Waldvogel FA, Vaudaux P, Nydegger UE | J Infect Dis | 10.1093/infdis/146.4.487 | 1982 | |
| Pathogenicity | Polyclonal response of human lymphocytes to bacterial cell walls, peptidoglycans and teichoic acids. | Rasanen L, Mustikkamaki UP, Arvilommi H | Immunology | 1982 | ||
| Enzymology | Precipitating antibodies against Staphylococcus aureus in experimental rabbit osteomyelitis, investigated by means of quantitative immunoelectrophoretic methods. | Espersen F, Hedstrom SA | Acta Pathol Microbiol Immunol Scand B | 10.1111/j.1699-0463.1982.tb00107.x | 1982 | |
| Pathogenicity | Protein A adsorption of acute myelogenous leukemia serum induces in vitro blast lysis. | Miller WJ, Branda RF, Hurd DD, Wachsman W, Nelson NL, Jacob HS | Blood | S0006-4971(20)76053-2 | 1982 | |
| Enzymology | Staphylococcus aureus antibodies in patients with staphylococcal septicemia. Comparisons between solid-phase radioimmunoassay and crossed immunoelectrophoresis. | Christensson B, Espersen F, Hedstrom SA, Kronvall G | Scand J Infect Dis | 10.3109/inf.1982.14.issue-2.18 | 1982 | |
| Enzymology | Quantitative aspects of binding of canine serum immunoglobulins of Staphylococcus aureus protein A. | Miele JA, Krakowka S | Am J Vet Res | 1981 | ||
| Pathogenicity | Cell walls, peptidoglycans, and teichoic acids of gram-positive bacteria as polyclonal inducers and immunomodulators of proliferative and lymphokine responses of human B and T lymphocytes. | Rasanen L, Arvilommi H | Infect Immun | 10.1128/iai.34.3.712-717.1981 | 1981 | |
| Enzymology | Pleiotropic compensation in the regulation of extracellular protein formation by a low alpha-toxin-producing variant of Staphylococcus aureus (Wood 46). | Coleman G | J Gen Microbiol | 10.1099/00221287-122-1-11 | 1981 | |
| Immunoperoxidase and electron microscopy studies of staphylococcal lipoteichoic acid. | Aasjord P, Grov A | Acta Pathol Microbiol Scand B | 10.1111/j.1699-0463.1980.tb02602.x | 1980 | ||
| Pathogenicity | Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro. | Hof DG, Repine JE, Peterson PK, Hoidal JR | Am Rev Respir Dis | 10.1164/arrd.1980.121.1.65 | 1980 | |
| Cultivation | Staphylococcus aureus protein A: quantitation by microhemagglutination. | Gonzalez-Aguilar H, Lopez-Revilla R | Arch Invest Med (Mex) | 1980 | ||
| Pathogenicity | Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. | Vaudaux P, Waldvogel FA | Antimicrob Agents Chemother | 10.1128/AAC.16.6.743 | 1979 | |
| Pathogenicity | Opsonic activity of normal human cerebrospinal fluid for selected bacterial species. | Tofte RW, Peterson PK, Kim Y, Quie PG | Infect Immun | 10.1128/iai.26.3.1093-1098.1979 | 1979 | |
| Metabolism | Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions. | Lew PD, Zubler R, Vaudaux P, Farquet JJ, Waldvogel FA, Lambert PH | J Clin Invest | 10.1172/JCI109306 | 1979 | |
| Enzymology | Effect of protein A on the antistaphylococcal defence mechanisms of the murine lung. | Hsieh S, Goldstein E, Lippert W, Margulies L | J Infect Dis | 10.1093/infdis/138.6.754 | 1978 | |
| Metabolism | Lung clearance of Staphylococcus aureus strains with differing protein A content: protein A effect on in vivo clearance. | Gross GN, Rehm SR, Toews GB, Hart DA, Pierce AK | Infect Immun | 10.1128/iai.21.1.7-9.1978 | 1978 | |
| Pathogenicity | Suppression of Staphylococcus aureus extracellular nuclease and alpha-toxin synthesis by acetylmethylcarbinol. | Udou T, Ichikawa Y | Infect Immun | 10.1128/iai.20.3.873-874.1978 | 1978 | |
| Phylogeny | Behavior of a vigorous alpha- or beta-hemolysin-producing strain of Staphylococcus aureus in the cutaneous tissue of mice. | Takeuchi S, Nakajima Y, Shoya S, Suto T | Microbiol Immunol | 10.1111/j.1348-0421.1978.tb00370.x | 1978 | |
| Cultivation | Comparison of the patterns of increased in alpha-toxin and total extracellular protein by Staphylococcus aureus (Wood 46) grown in media supporting widely differing growth characteristics. | Coleman G, Abbas-Ali B | Infect Immun | 10.1128/iai.17.2.278-281.1977 | 1977 | |
| Metabolism | The characteristics of extracellular protein secretion by Staphylococcus aureus (Wood 46) and their relationship to the regulation of alpha-toxin formation. | Abbas-ali B, Coleman G | J Gen Microbiol | 10.1099/00221287-99-2-277 | 1977 | |
| Enzymology | Cholesteryl de-esterifying enzyme from Staphylococcus aureus: separation from alpha toxin, purification, and some properties. | Harvie NR | Infect Immun | 10.1128/iai.15.3.863-870.1977 | 1977 | |
| Pathogenicity | Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. | Ringden O, Rynnel-Dagoo B, Waterfield EM, Moller E, Moller G | Scand J Immunol | 10.1111/j.1365-3083.1977.tb00355.x | 1977 | |
| Metabolism | Spontaneous alpha-toxin mutants of Staphylococcus aureus. | Dalen AB | Acta Pathol Microbiol Scand B | 10.1111/j.1699-0463.1976.tb01949.x | 1976 | |
| Enzymology | Single-tube mixed agglutination test for the detection of staphylococcal protein A. | Maxim PE, Mathews HL, Mengoli HF | J Clin Microbiol | 10.1128/jcm.4.5.418-422.1976 | 1976 | |
| Metabolism | Trypsin-mediated activation of the alpha-haemolysin of Staphylococcus aureus. | Wiseman GM, Caird JD, Fackrell HB | J Med Microbiol | 10.1099/00222615-8-1-29 | 1975 | |
| Pathogenicity | Antigen analysis of Staphylococcus aureus strains sensitive and resistant to antibiotics. | Jagicza A, Varosi I, Sztankov L | Ann Immunol Hung | 1975 | ||
| Phylogeny | Comparison of purified alpha-toxins from various strains of Staphylococcus aureus. | Goode RL, Baldwin JN | Appl Microbiol | 10.1128/am.28.1.86-90.1974 | 1974 | |
| Bactericidal activity of aerobic and anaerobic polymorphonuclear neutrophils. | Mandell GL | Infect Immun | 10.1128/iai.9.2.337-341.1974 | 1974 | ||
| Cultivation | Production of staphylococcal alpha toxin. II. Glucose repression of toxin formation. | Duncan JL, Cho GJ | Infect Immun | 10.1128/iai.6.5.689-694.1972 | 1972 | |
| Cultivation | Production of staphylococcal alpha toxin. I. Relationship between cell growth and toxin formation. | Duncan JL, Cho GJ | Infect Immun | 10.1128/iai.4.4.456-461.1971 | 1971 | |
| Enzymology | Bacteriolytic enzymes from Staphylococcus aureus. Purification of an endo-beta-N-acetylglucosaminidase. | Wadstrom T, Hisatsune K | Biochem J | 10.1042/bj1200725 | 1970 | |
| Enzymology | A protein component of the cell surface of Staphylococcus aureus. | James AM, Brewer JE | Biochem J | 10.1042/bj1080257 | 1968 | |
| Metabolism | Infection in mouse peritoneal cavity with a pyrimidine-requiring mutant and naturally occurring Staphylococcus aureus strains. | Mathieu LG, De Repentigny J, Turgeon S, Sonea S | J Bacteriol | 10.1128/jb.94.1.13-18.1967 | 1967 | |
| Pathogenicity | Identification of staphylococcal hemolysins by an electrophoretic localization technique. | Haque RU | J Bacteriol | 10.1128/jb.93.2.525-530.1967 | 1967 | |
| DIFFERENTIATION BY IMMUNODIFFUSION AND BY QUANTITATIVE IMMUNOFLUORESCENCE BETWEEN 5-FLUOROURACIL-TREATED AND NORMAL CELLS FROM A TOXINOGENIC STAPHYLOCOCCUS AUREUS STRAIN. | DEREPENTIGNY J, SONEA S, FRAPPIER A | J Bacteriol | 10.1128/JB.88.2.444-448.1964 | 1964 |
| #8735 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 20491 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #39847 | Collection of Institut Pasteur ; Curators of the CIP; CIP 52.1 |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #68371 | Automatically annotated from API 50CH acid . |
| #68375 | Automatically annotated from API ID32STA . |
| #68382 | Automatically annotated from API zym . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive14490.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data